These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1903142)
21. Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. Stevens DB; Gould KE; Swanborg RH J Neuroimmunol; 1994 Apr; 51(1):77-83. PubMed ID: 7512580 [TBL] [Abstract][Full Text] [Related]
22. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester. Higuchi M; Aggarwal BB J Biol Chem; 1993 Mar; 268(8):5624-31. PubMed ID: 8383675 [TBL] [Abstract][Full Text] [Related]
23. [Inhibition of proto-oncogene c-myc expression with recombinant human tumor necrosis factor-alpha and interferon-gamma in HL-60 cell lines and acute myelocytic leukemic fresh cells]. Yuan YC; Shen SY Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):302-5. PubMed ID: 7835139 [TBL] [Abstract][Full Text] [Related]
24. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells. Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166 [TBL] [Abstract][Full Text] [Related]
25. Effects of recombinant human tumor necrosis factor alpha, lymphotoxin, and Escherichia coli lipopolysaccharide on hemodynamics, lung microvascular permeability, and eicosanoid synthesis in anesthetized sheep. Kreil EA; Greene E; Fitzgibbon C; Robinson DR; Zapol WM Circ Res; 1989 Aug; 65(2):502-14. PubMed ID: 2665972 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma. Galve-de Rochemonteix B; Nicod LP; Dayer JM Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179 [TBL] [Abstract][Full Text] [Related]
27. Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man. Michelmann I; Böckmann D; Nürnberger W; Eckhof-Donovan S; Burdach S; Göbel U Ann Hematol; 1997 Apr; 74(4):179-84. PubMed ID: 9174546 [TBL] [Abstract][Full Text] [Related]
28. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Batten P; Yacoub MH; Rose ML Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424 [TBL] [Abstract][Full Text] [Related]
29. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: paradoxical induction of IFN-gamma and TNF-alpha receptor expression. Alvaro-Gracia JM; Yu C; Zvaifler NJ; Firestein GS J Clin Immunol; 1993 May; 13(3):212-8. PubMed ID: 8391545 [TBL] [Abstract][Full Text] [Related]
30. Synergistic antitumor effect of glycosylated recombinant human lymphotoxin with human interferon-gamma on lymphotoxin-sensitive human tumor. Kawatsu M; Funahashi I; Kajikawa T; Takeo K; Asahi T; Yamashita T; Kawaharada H; Watanabe K J Interferon Res; 1990 Oct; 10(5):519-29. PubMed ID: 2125632 [TBL] [Abstract][Full Text] [Related]
31. TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members. Voon DC; Subrata LS; Karimi M; Ulgiati D; Abraham LJ J Immunol; 2004 Apr; 172(7):4332-41. PubMed ID: 15034048 [TBL] [Abstract][Full Text] [Related]
32. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686 [TBL] [Abstract][Full Text] [Related]
33. Regulation of lymphotoxin-beta by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells. Voon DC; Subrata LS; Abraham LJ J Interferon Cytokine Res; 2001 Nov; 21(11):921-30. PubMed ID: 11747624 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D54-MG. Bethea JR; Gillespie GY; Chung IY; Benveniste EN J Neuroimmunol; 1990 Nov; 30(1):1-13. PubMed ID: 2172302 [TBL] [Abstract][Full Text] [Related]
35. Human T cells from autoimmune and normal individuals can produce tumor necrosis factor. Turner M; Londei M; Feldmann M Eur J Immunol; 1987 Dec; 17(12):1807-14. PubMed ID: 3121358 [TBL] [Abstract][Full Text] [Related]
36. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice. McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349 [TBL] [Abstract][Full Text] [Related]
37. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity. Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831 [TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (IFN-alpha) and interferon-gamma (IFN-gamma) receptors on human normal and scleroderma dermal fibroblasts in vitro. Berman B; Wietzerbin J J Dermatol Sci; 1992 Mar; 3(2):82-90. PubMed ID: 1318071 [TBL] [Abstract][Full Text] [Related]
40. Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-alpha. Pang XP; Yoshimura M; Hershman JM Thyroid; 1993; 3(4):325-30. PubMed ID: 8118227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]